Literature DB >> 28074085

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine.

Wang Junwei¹, Zhang Xiumin¹, Ye Jing¹, Yang Shoujing¹, Li Zengshan².

Abstract

[This corrects the article DOI: 10.1186/s12935-016-0317-2.].

Entities: Chemical Disease Gene

Year: 2017 PMID： 28074085 PMCID： PMC5219739 DOI： 10.1186/s12935-016-0375-5

Source DB: PubMed Journal: Cancer Cell Int ISSN： 1475-2867 Impact factor: 5.722

Erratum to: Cancer Cell Int (2016) 16:45 DOI 10.1186/s12935-016-0317-2

Following publication of the original article [1] it was brought to our attention that the second author name had been misspelt. Please note that the second author name should be “Zhang Xiumin” and not “Zhan Xiumin” as was originally presented.

1 in total

1. In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine.

Authors: Wang Junwei; Zhan Xiumin; Ye Jing; Yang Shoujing; Li Zengshan
Journal: Cancer Cell Int Date: 2016-06-17 Impact factor: 5.722

1 in total